Lead Product(s) : Benzocaine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Johnson & Johnson Innovative Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study to Determine the Efficacy and Safety of a Benzocaine Lozenge for Treatment of Sore Throat.
Details : Benzocaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pharyngitis.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 14, 2018
Lead Product(s) : Benzocaine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Johnson & Johnson Innovative Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
Details : Benzocaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 17, 2017
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Benzocaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 20, 2014
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzocaine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : AR01 is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Otitis Media.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 28, 2014
Lead Product(s) : Benzocaine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzocaine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : AR01 is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Otitis Media.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
January 24, 2014
Lead Product(s) : Benzocaine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : Solta Medical
Deal Size : Inapplicable
Deal Type : Inapplicable
Comparison Study on Topical Anesthetic Agents (LMX4 and BLT) Prior to Fractional Skin Resurfacing
Details : Benzocaine is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 29, 2013
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : Solta Medical
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of FAECC Scale (Modified FLACC) to Evaluate Ear Pain in Children With Acute Otitis Media
Details : Benzocaine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Pain.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 01, 2012
Lead Product(s) : Benzocaine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
